Kathleen Kearney, MD
Interventional Cardiology · Seattle, WANPI 1144459462
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Abbott at 24.9% of the total. Reporting peaked in 2024 at $118,537 and has fallen 50.8% since, to $58,284 in 2025. Among interventional cardiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 633 payments — averaging $708.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$112K
- Medtronic$96K
- Boston Scientific$92K
- Abiomed$52K
- Teleflex LLC$25K
- Shockwave Medical, Inc$13K
- plus $57K from 16 others
Across 75 payments — averaging $4715.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arrow International, Inc.$207K
- Boston Scientific$85K
- Shockwave Medical, Inc$42K
- Siemens Medical Solutions USA, Inc.$14K
- Teleflex LLC$5K
What the payments were for
- Consulting fees$185,83241%
- Speaking & faculty fees$174,95839%
- Grants$1,6350%
- Travel & lodging$59,51513%
- Food & beverage$26,4286%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 174 | $111,722 |
| Medtronic(2 entities) | 113 | $96,445 |
| Boston Scientific | 128 | $92,044 |
| Abiomed | 60 | $52,447 |
| Teleflex LLC | 35 | $24,880 |
| Shockwave Medical, Inc | 19 | $13,372 |
| Reflow Medical Inc | 3 | $12,986 |
| Cardiovascular Systems Inc. | 24 | $10,982 |
| Philips North America LLC | 18 | $9,292 |
| Vascular Solutions, Inc. | 3 | $7,613 |
| Asahi Intecc USA, Inc. | 25 | $5,629 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $2,000 |
| Arrow International, Inc. | 3 | $1,973 |
| Biotronik Inc. | 3 | $1,843 |
| Novo Nordisk | 1 | $1,570 |
| Terumo Medical Corporation | 4 | $1,134 |
| Siemens Medical Solutions USA, Inc. | 5 | $910 |
| Verge Medical, Inc. | 4 | $649 |
| Corindus Inc. | 6 | $521 |
| W. L. Gore & Associates, Inc. | 1 | $123 |
| Impulse Dynamics (USA) Inc. | 1 | $122 |
| Edwards Lifesciences | 2 | $117 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$81,472
- Impella$50,533
- RESOLUTE ONYX$33,452
- GENERAL VASCULAR ACCESS$28,814
- TURNPIKE$17,350
- ONYX FRONTIER$14,621
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$13,182
- (9520) IGT Devices Undivided$9,036
- Catheter - Specialty Access$7,613
- GENERAL - THERAPIES$7,565
- HI-TORQUE BALANCE$7,416
- Diamondback Coronary$7,067
- Resolute$6,038
- XIENCE SKYPOINT$6,000
- DRAGONFLY OPSTAR$3,785
- Asahi Coronary Wires$3,760
- GENERAL - STRUCTURAL HEART$3,500
- Dragonfly OCT$3,236
- GUIDELINER$3,162
- Coronary Orbital Atherectomy System$2,731
How this compares
$448,374 in reported general payments places this provider in the 95th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 14 | $120 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Seattle
- William LombardiSeattle$902K
- Danny DvirSeattle$374K
- James McCabeSeattle$289K
- Christopher BrownSeattle$266K
- Lorenzo AzzaliniSeattle$233K
- Sidakpal PanaichSeattle$214K
- Christine ChungSeattle$210K
- Sameer GafoorSeattle$80K
- Ravi HiraSeattle$64K
- Ming ZhangSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.